Malignant Phosphaturic Mesenchymal Tumor

A phosphaturic mesenchymal tumor that has metastasized from its original site of growth to other anatomic sites.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
01220012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
RATIONALE Phosphaturic mesenchymal tumor (PMT) is a new tumor entity of soft tissue and bone tumor recently accepted by the World… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2017
2017
Key Messages Octreotide can be used as an adjunctive therapy to increase phosphorus levels in patients with tumor-induced… (More)
  • figure 1
  • figure 2
Is this relevant?
2014
2014
Tumor-induced osteomalacia (TIO) is a rare acquired form of hypophosphatemia commonly associated with phosphaturic mesenchymal… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 6
  • figure 4
Is this relevant?
2011
2011
Phosphaturic mesenchymal tumors are rare neoplasms predominantly originating in the trunk and extremities. Malignant variants are… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2009
2009
The majority of the oncogenic osteomalacia-associated mesenchymal tumors are considered to belong to the category of phosphaturic… (More)
Is this relevant?
2001
2001
Phosphaturic mesenchymal tumor is a rare neoplasm which causes osteomalacia or rickets. The tumor typically follows a benign… (More)
  • figure 4
  • figure 5
Is this relevant?